GAP-43 and BASP1 in Axon Regeneration: Implications for the Treatment of Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Growth-associated protein-43 (GAP-43) and brain acid-soluble protein 1 (BASP1) regulate actin dynamics and presynaptic vesicle cycling at axon terminals, thereby facilitating axonal growth, regeneration, and plasticity. These functions highly depend on changes in GAP-43 and BASP1 expression levels and post-translational modifications such as phosphorylation. Interestingly, examinations of GAP-43 and BASP1 in neurodegenerative diseases reveal alterations in their expression and phosphorylation profiles. This review provides an overview of the structural properties, regulations, and functions of GAP-43 and BASP1, highlighting their involvement in neural injury response and regeneration. By discussing GAP-43 and BASP1 in the context of neurodegenerative diseases, we also explore the therapeutic potential of modulating their activities to compensate for neuron loss in neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134
Involvement of a calcineurin/ inhibitor-1 phosphatase cascade in hippocampal long-term depression
Mulkey, R. M., Endo, S., Shenolikar, S., & Malenka, R. C. (1994) · Nature · doi:10.1038/369486a0 · Cited by 1,083
Kuchibhotla, K. V., Goldman, S. T., Lattarulo, C. R., Wu, H.-Y., Hyman, B. T., & Bacskai, B. J. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.008 · Cited by 614 · cited 1×
“CaMKII and CaN critically regulate synaptic functions (Mulkey et al., 1994; Pang et al., 2010) and contribute to synaptopathy in neurodegenerative diseases (Kuchibhotla et al., 2008; Gu et al., 2009; Teravskis et al., 2018).”
BackgroundFactors affecting excitatory amino acid release following severe human head injury
Bullock, R., Zauner, A., Woodward, J. J., Myseros, J., Choi, S. C., Ward, J. D., Marmarou, A., & Young, H. F. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.89.4.0507 · Cited by 526
BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504
Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo
Fulga, T. A., Elson-Schwab, I., Khurana, V., Steinhilb, M. L., Spires, T. L., Hyman, B. T., & Feany, M. B. (2007) · Nature Cell Biology · doi:10.1038/ncb1528 · Cited by 452
Carmichael, S. T., Archibeque, I., Luke, L., Nolan, T., Momiy, J., & Li, S. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.01.004 · Cited by 421
Production of cytokines following brain injury: Beneficial and deleterious for the damaged tissue
Morganti-Kossman, M. C., Lenzlinger, P. M., Hans, V, Stahel, P., Csuka, E., Ammann, E., Stocker, R., Trentz, O., & Kossmann, T. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000227 · Cited by 267
Cytoskeleton dynamics in axon regeneration
Blanquie, O., & Bradke, F. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.02.024 · Cited by 189 · cited 2×
“Regulation of the actin cytoskeleton is important for axon guidance and growth (Gomez and Letourneau, 2014; Blanquie and Bradke, 2018), endocytosis (Smythe and Ayscough, 2006), and exocytosis (Eitzen, 2003).”
BackgroundADF/Cofilin-Actin Rods in Neurodegenerative Diseases
Bamburg, J. R., Bernstein, B. W., Davis, R. C., Flynn, K. C., Goldsbury, C., Jensen, J. R., Maloney, M. T., Marsden, I. T., Minamide, L. S., Pak, C. W., et al. (2010) · Current Alzheimer Research · doi:10.2174/156720510791050902 · Cited by 173
Chung, S., Eckrich, M., Perrone-Bizzozero, N., Kohn, D. T., & Furneaux, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6593 · Cited by 142
Quattrone, A., Pascale, A., Nogues, X., Zhao, W., Gusev, P., Pacini, A., & Alkon, D. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191388398 · Cited by 137
Kommaddi, R. P., Das, D., Karunakaran, S., Nanguneri, S., Bapat, D., Ray, A., Shaw, E., Bennett, D. A., Nair, D., & Ravindranath, V. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.2127-17.2017 · Cited by 135
Bronicki, L. M., & Jasmin, B. J. (2013) · RNA · doi:10.1261/rna.039164.113 · Cited by 126 · cited 4×
“Post-transcriptional Regulation in Neurodegenerative Diseases Post-transcriptional regulation allows a rapid adjustment of the location and level of protein expression (Bronicki and Jasmin, 2013).”
BackgroundInfluentialThe landscape of multiscale transcriptomic networks and key regulators in Parkinson’s disease
Wang, Q., Zhang, Y., Wang, M., Song, W.-M., Shen, Q., McKenzie, A., Choi, I., Zhou, X., Pan, P.-Y., Yue, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13144-y · Cited by 121
Alfonso, S. I., Callender, J. A., Hooli, B., Antal, C. E., Mullin, K., Sherman, M. A., Lesné, S. E., Leitges, M., Newton, A. C., Tanzi, R. E., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aaf6209 · Cited by 103 · cited 2×
“On the other hand, whole genome-sequencing of lateonset Alzheimer’s Disease patients identified gain-of-function mutations in PKC (Alfonso et al., 2016).”
BackgroundCichon, J., Sun, C., Chen, B., Jiang, M., Chen, X. A., Sun, Y., Wang, Y., & Chen, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.301911 · Cited by 95
Tagawa, K., Homma, H., Saito, A., Fujita, K., Chen, X., Imoto, S., Oka, T., Ito, H., Motoki, K., Yoshida, C., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu475 · Cited by 86 · cited 5×
“This analysis identified 5 phosphosites in GAP-43 and 6 phosphosites in BASP1 (Figure 2 shows equivalent sites in rat proteins based on sequence alignment in Clustal Omega; Tagawa et al., 2015).”
BackgroundMethodInfluentialAssociation between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease
Noureddine, M. A., Qin, X.-J., Oliveira, S. A., Skelly, T. J., van der Walt, J., Hauser, M. A., Pericak-Vance, M. A., Vance, J. M., & Li, Y.-J. (2005) · Human Genetics · doi:10.1007/s00439-005-1259-2 · Cited by 76 · cited 5×
“GAP-43 and BASP1 are also regulated by other kinases and phosphatases, and such post-translational modifications are implicated in Alzheimer’s and Parkinson’s Diseases.”
BackgroundInfluentialTsai, K.-C., Cansino, V. V., Kohn, D. T., Neve, R. L., & Perrone-Bizzozero, N. I. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-06-01950.1997 · Cited by 66 · cited 1×
“The stabilization of GAP43 mRNA is dependent on the highly conserved 3 untranslated region (Kohn et al., 1996; Tsai et al., 1997), where the neuralspecific RNA-binding protein HuD binds (Chung et al.”
BackgroundAnderson, K. D., Merhege, M. A., Morin, M., Bolognani, F., & Perrone-Bizzozero, N. I. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00103-1 · Cited by 64 · cited 2×
“HuD post-transcriptionally regulates GAP-43 during neuritogenesis, regeneration, and learning (Anderson et al., 2001, 2003; Quattrone et al., 2001; Pascale et al., 2004).”
BackgroundAmadio, M., Pascale, A., Wang, J., Ho, L., Quattrone, A., Gandy, S., Haroutunian, V., Racchi, M., & Pasinetti, G. M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0967 · Cited by 63 · cited 2×
“The level of HuD was shown to be decreased in the hippocampus of Alzheimer’s Disease patients (Amadio et al., 2009).”
Background
Cited by
Ma, Y., Wang, H., Wang, Q., Cao, X., & Gao, H. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.139424 · Cited by 103
Metadata
- Authors
- Chung, D., Shum, A., & Caraveo, G.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2020-09-03
- Volume
- 8
- Pages
- 567537-567537
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W3082016244
- Cited by
- 203
- References
- 27
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.